A 42-year-old woman underwent a breast biopsy due to an abnormal mammogram. Even though the biopsy analysis yielded benign findings, the woman’s family history with pancreatic cancer prompted the surgeon to order a 70-gene panel test to assess if she had inherited a pathogenic genetic variant that increased her cancer risk.

The results indicated the woman had a pathogenic variant in the RAD50 gene and a variant of uncertain significance (VUS) in the PALB2 gene. The surgeon recommended the woman undergo risk-reducing surgery and remove both her breasts based on the pathogenic RAD50 variant and told her not to worry about the VUS in PALB2.

To read the full article, click here.